India, June 3 -- Def Leppard have announced new Fall 2026 tour dates in the U.S., Mexico and South America. Def Leppard Live 2026 Fall Tour will feature Extreme as special guest during October and No... Read More
India, June 3 -- MiniMed Group, Inc. (MMED) shares jumped 14.88 percent, gaining $1.83 to $14.13 on Wednesday, over the company's revenue growth and fiscal 2027 outlook despite a wider fourth-quarter ... Read More
India, June 3 -- Indian shares tumbled in early trade on Wednesday, with IT stocks coming under heavy selling pressure after the U.S.-listed shares of both Infosys and Wipro declined between 2.5 perce... Read More
India, June 3 -- Lily Allen has teamed up with British pop star JADE for a remix of her West End Girl track "Beg for Me." JADE sings, "If we're being honest it's better to find out than to find out i... Read More
India, June 2 -- Cardiff Oncology Inc. (CRDF), a clinical-stage biotechnology company, on Tuesday announced positive Phase 2 results for Onvansertib in combination with standard-of-care regimens in tr... Read More
India, June 2 -- Relay Therapeutics, Inc. (RLAY) stock surged 18.21 percent to $16.86, gaining $2.60 on Tuesday, marking a sharp upward move despite no company-specific news. The stock is currently t... Read More
India, June 2 -- Rezolute Inc. (RZLT), a late-stage company focused on ultra-rare diseases, announced positive interim results from its ongoing Phase 3 upLIFT study of Ersodetug in patients with tumor... Read More
India, June 2 -- Pasithea Therapeutics Corp. (KTTA), a clinical-stage biotechnology company, announced it has received Orphan Drug Designation for PAS-004 in treatment of Amyotrophic Lateral Sclerosis... Read More
India, June 2 -- Manchester Orchestra have released a new live album, Union Chapel (London, England), via Loma Vista Recordings. In a personal letter shared with fans, Manchester Orchestra's Andy Hul... Read More
India, June 2 -- Candel Therapeutics Inc. (CADL), a clinical-stage biopharmaceutical company, on Tuesday announced encouraging results from the Phase 3 trial for Aglatimagene in treating high-risk loc... Read More